Prime Medicine, Inc. (PRME) stock
PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.27+0.38 (+9.77%)
Close on Nov 13, 2026Market cap $774.48MP/E –Yield –
Prime Medicine profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Prime Medicine's profit margin for the twelve months ending Dec 31, 2025 was -4342.4%. For fiscal 2025 it was -4342.4%, against -6566.6% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4342.4% | +2224.2 |
| FY2024 | Dec 31, 2024 | -6566.6% | −6501.2 |
| FY2020 | Dec 31, 2020 | -65.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -926.7% | +2642.0 |
| Q4 FY2025 | Dec 31, 2025 | -5498.7% | −3562.1 |
| Q3 FY2025 | Sep 30, 2025 | -4129.1% | +20999.1 |
| Q2 FY2025 | Jun 30, 2025 | -4716.7% | +3026.3 |
| Q1 FY2025 | Mar 31, 2025 | -3568.8% | – |
| Q4 FY2024 | Dec 31, 2024 | -1936.6% | – |
| Q3 FY2024 | Sep 30, 2024 | -25128.2% | – |
| Q1 FY2024 | Mar 31, 2024 | -7743.0% | – |
See a number that looks wrong?